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Background 
Despite the development of various insulin protocols, 
perioperative hypo- and hyperglycaemic events during 
cardiopulmonary bypass remain a point of concern. 
The University of Ghent Insulin Protocol has been found 
to keep perioperative glycaemia within narrow limits, 
while diabetes mellitus, use of corticosteroids and age 
are risk factors for deviation of pre-induction glycaemia. 
Methods 
Retrospective cohort study. 
After exclusion, data from 776 
cardiac surgery patients remained.  
 
Relative risks were calculated for 
the following variables:  
- Redo operation 
- CPB duration > 60 min 
- Age > 70 years 
- Gender 
- Temperature on CPB < 32°C 
- Nadir haematocrit < 24% 
- Inotropic and/or vasoactive  
support 
- Corticosteroids 
- Diabetes mellitus 
 
The statistically significant 
variables were included in a 
multiple regression analysis. 
Results  
 
Conclusion 
The following variables appeared to be independent risk factors for hyper- or hypoglycaemic 
events when using the UGIP: 
- Glycaemia < 70 mg/dL: corticosteroids and inotropic and/or vasoactive agents. 
- Glycaemia > 180 mg/dL: diabetes mellitus. 
Goal of Study  
In this study we sought to identify independent risk factors 
for significant perioperative hyperglycaemic (> 180 mg/dL) 
and hypoglycaemic (< 70 mg/dL) events when using the 
UGIP. 
